Par Drugs & Chemicals Ltd Achieves Upper Circuit Limit Amid Strong Market Momentum
Par Drugs & Chemicals Ltd experienced notable trading activity today, reaching its upper circuit limit with a high of 111.51. The stock outperformed its sector and maintained a consistent trading range. It is currently above several moving averages, indicating strong market momentum and sufficient liquidity for trading.
Par Drugs & Chemicals Ltd, a microcap player in the Chemicals & Petrochemicals industry, has shown significant activity today as it hit its upper circuit limit. The stock reached a high price of 111.51, reflecting a notable increase of 5.31 points or 5.0% from its previous close. The last traded price also stood at 111.51, indicating a strong performance throughout the trading session.The stock's performance today outpaced its sector, outperforming by 5.35%. It maintained a consistent trading range, with the intraday low matching the high at 111.51. Total traded volume was recorded at approximately 0.08391 lakh shares, resulting in a turnover of around 0.093568041 crore.
In terms of moving averages, Par Drugs & Chemicals is currently above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. The liquidity of the stock is deemed sufficient for trading, based on 2% of the 5-day average traded value.
Overall, Par Drugs & Chemicals Ltd has demonstrated robust performance today, reflecting positive momentum in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
